Page results
-
The Headache Service provides advice and treatment to patients referred for the management of all headache disorders.
-
Our team deliver care to people with MS and aim to provide specialist services, share information on how to manage symptoms, offer education sessions, medication options and rehabilitation services.
-
The Neurometabolic unit provides a unique range of investigations and clinical laboratory advice encompassing mitochondrial, neurotransmitter, pterin and amino acid disorders.
-
The clinical management of neuromuscular muscle wasting diseases such as motor neuron disease, myasthenia gravis, muscular dystrophy and peripheral neuropathy.
-
Typically, patient care is multidisciplinary led by consultant neuro-ophthalmologists and neurologists.
-
The department is responsible for a wide range of neurophysiological procedures, principally electromyography (EMG) and nerve conduction studies, EMG-guided botulinum toxin (BoTox) injections, electroencephalography (EEG), evoked potentials (EPs) and intra-operative monitoring (IOM)
-
UCLH is the only Supra-Centre in England to deliver Intracranial Stereotactic Radiosurgery and Stereotactic Radiotherapy Services (SRS/SRT) as part of an integrated neurosurgical and neuro-oncology service to patients.
-
The Headache and Facial Pain Group is internationally recognised as a centre of clinical and academic excellence in the management of complex head and facial pain disorders.
-
The plasma exchange service at the National Hospital treats patients with neuroimmunological diseases such as Guillain-Barré syndrome and myasthenia gravis.
-
We provide a specialist spinal surgery service including treatment of degenerative spinal conditions, artificial discs, spinal injury, spinal tumours (intra and extra dural, including metastatic disease), scoliosis and syringomyelia.
File results
-
FOI/2024/0514 - Viscosupplementation injections/ spend
-
FOI/2024/0518 - Post partum balloons buying/ usage numbers
-
FOI/2024/0520 - Treatment of melanoma
-
FOI/2024/05523 - Dabrafenib + Trametinib cancer treatment for metastatic and adjuvant melanoma/ lung/ colorectal cancer
-
FOI/2024/0527 - Treatment for renal cell carcinoma
-
FOI/2024/0528 - Open MRIs referrals for patient size/ spend on specialist bariatric equipment 2017-2024
-
FOI/2024/0529 - Medical Associate Professionals (MAPs) at Trust
-
FOI/2024/0530 - Radiology/ imaging examinations/ patient access to radiology images
-
FOI/2024/0532 - Patient treatment/ care/ consent
-
FOI/2024/0543 - Guidelines, policies for the treatment of obesity/ pathways for Tier 3 or Tier 4 weight management services